{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:32:21Z","timestamp":1784043141313,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"General Program of National Natural Science Foundation of China","award":["82174199"],"award-info":[{"award-number":["82174199"]}]},{"name":"Shanghai University of Traditional Chinese Medicine Industry Development Center Medical and Nursing Integrated Science and Technology Innovation Project","award":["602069D"],"award-info":[{"award-number":["602069D"]}]},{"name":"the third batch of young Chinese name training program of LongHua Hospital Shanghai University of Traditional Chinese Medicine","award":["RC-2017-01-14"],"award-info":[{"award-number":["RC-2017-01-14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00210-025-04182-z","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T23:33:54Z","timestamp":1745364834000},"page":"14165-14173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stachydrine hydrochloride induces cell senescence and ferroptosis of castration-resistant prostate cancer"],"prefix":"10.1007","volume":"398","author":[{"given":"Siyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"4182_CR1","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.4161\/cc.28471","volume":"13","author":"A Aravinthan","year":"2014","unstructured":"Aravinthan A, Mells G, Allison M, Leathart J, Kotronen A, Yki-Jarvinen H, Daly AK, Day CP, Anstee QM, Alexander G (2014) Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease. Cell Cycle 13:1489\u20131494","journal-title":"Cell Cycle"},{"key":"4182_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154066","volume":"100","author":"X Bao","year":"2022","unstructured":"Bao X, Liu Y, Huang J, Yin S, Sheng H, Han X, Chen Q, Wang T, Chen S, Qiu Y, Zhang C, Yu H (2022) Stachydrine hydrochloride inhibits hepatocellular carcinoma progression via LIF\/AMPK axis. Phytomedicine 100:154066","journal-title":"Phytomedicine"},{"key":"4182_CR3","doi-asserted-by":"crossref","unstructured":"Bebber CM, Muller F, Prieto Clemente L, Weber J, von Karstedt S (2020) Ferroptosis in cancer cell biology. Cancers (Basel) 12","DOI":"10.3390\/cancers12010164"},{"key":"4182_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/pros.23446","volume":"78","author":"H Bonkhoff","year":"2018","unstructured":"Bonkhoff H (2018) Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression. Prostate 78:2\u201310","journal-title":"Prostate"},{"key":"4182_CR5","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"4182_CR6","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.7150\/jca.84943","volume":"14","author":"H Cao","year":"2023","unstructured":"Cao H, Feng Y, Sun P, Chen L, Wang D, Gao R (2023) Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6\/STAT3 pathway. J Cancer 14:2246\u20132254","journal-title":"J Cancer"},{"key":"4182_CR7","first-page":"1812","volume":"14","author":"H Cao","year":"2022","unstructured":"Cao H, Wang D, Gao R, Feng Y, Chen L (2022) Qi Ling decreases paclitaxel resistance in the human prostate cancer by reversing tumor-associated macrophages function. Aging (Albany N y) 14:1812\u20131821","journal-title":"Aging (Albany N y)"},{"key":"4182_CR8","first-page":"23096","volume":"13","author":"H Cao","year":"2021","unstructured":"Cao H, Wang D, Sun P, Chen L, Feng Y, Gao R (2021) Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10\/miR-1271-5p\/TRIM66 axis. Aging (Albany N y) 13:23096\u201323107","journal-title":"Aging (Albany N y)"},{"key":"4182_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/CAD.0000000000001066","volume":"32","author":"X Chen","year":"2021","unstructured":"Chen X, Yan N (2021) Stachydrine inhibits TGF-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells through the TGF-beta\/Smad and PI3K\/Akt\/mTOR signaling pathways. Anticancer Drugs 32:786\u2013792","journal-title":"Anticancer Drugs"},{"key":"4182_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104755","volume":"155","author":"F Cheng","year":"2020","unstructured":"Cheng F, Zhou Y, Wang M, Guo C, Cao Z, Zhang R, Peng C (2020) A review of pharmacological and pharmacokinetic properties of stachydrine. Pharmacol Res 155:104755","journal-title":"Pharmacol Res"},{"key":"4182_CR11","doi-asserted-by":"crossref","unstructured":"Fischer C, Volani C, Komlodi T, Seifert M, Demetz E, Valente de Souza L, Auer K, Petzer V, von Raffay L, Moser P, Gnaiger E, Weiss G (2021) Dietary iron overload and Hfe(-\/-) related hemochromatosis alter hepatic mitochondrial function. antioxidants (Basel) 10","DOI":"10.3390\/antiox10111818"},{"key":"4182_CR12","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","volume":"81","author":"A Ghoochani","year":"2021","unstructured":"Ghoochani A, Hsu EC, Aslan M, Rice MA, Nguyen HM, Brooks JD, Corey E, Paulmurugan R, Stoyanova T (2021) Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer. Cancer Res 81:1583\u20131594","journal-title":"Cancer Res"},{"key":"4182_CR13","doi-asserted-by":"publisher","first-page":"1514158","DOI":"10.3389\/fphar.2025.1514158","volume":"16","author":"Y Gui","year":"2025","unstructured":"Gui Y, Xue G, Yuan Y, Wang J, Deng S, Gao F, Tian Y, Zhao Z, Fan H (2025) Stachydrine targeting tumor-associated macrophages inhibit colorectal cancer liver metastasis by regulating the JAK2\/STAT3 pathway. Front Pharmacol 16:1514158","journal-title":"Front Pharmacol"},{"key":"4182_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jsbmb.2004.10.016","volume":"92","author":"PL Harkonen","year":"2004","unstructured":"Harkonen PL, Makela SI (2004) Role of estrogens in development of prostate cancer. J Steroid Biochem Mol Biol 92:297\u2013305","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4182_CR15","doi-asserted-by":"crossref","unstructured":"Karthika C, Sureshkumar R, Zehravi M, Akter R, Ali F, Ramproshad S, Mondal B, Tagde P, Ahmed Z, Khan FS, Rahman MH, Cavalu S (2022) Multidrug resistance of cancer cells and the vital role of P-glycoprotein. Life (Basel) 12","DOI":"10.3390\/life12060897"},{"key":"4182_CR16","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/jcb.24464","volume":"114","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Yin B, Christudass CS, Terada N, Rajagopalan K, Fabry B, Lee DY, Shiraishi T, Getzenberg RH, Veltri RW, An SS, Mooney SM (2013) Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer. J Cell Biochem 114:1286\u20131293","journal-title":"J Cell Biochem"},{"key":"4182_CR17","first-page":"485","volume":"15","author":"F Kong","year":"2023","unstructured":"Kong F, Wang C, Zhang J, Wang X, Sun B, Xiao X, Zhang H, Song Y, Jia Y (2023) Chinese herbal medicines for prostate cancer therapy: from experimental research to clinical practice. Chin Herb Med 15:485\u2013495","journal-title":"Chin Herb Med"},{"key":"4182_CR18","doi-asserted-by":"publisher","first-page":"1223493","DOI":"10.3389\/fmolb.2023.1223493","volume":"10","author":"W Lai","year":"2023","unstructured":"Lai W, Chen J, Wang T, Liu Q (2023) Crosstalk between ferroptosis and steroid hormone signaling in gynecologic cancers. Front Mol Biosci 10:1223493","journal-title":"Front Mol Biosci"},{"key":"4182_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1474-9726.2006.00199.x","volume":"5","author":"BY Lee","year":"2006","unstructured":"Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, Kleijer WJ, DiMaio D, Hwang ES (2006) Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 5:187\u2013195","journal-title":"Aging Cell"},{"key":"4182_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fphar.2020.00132","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Sui X, Su Z, Yu C, Shi X, Johnson NL, Chu F, Li Y, Li K, Ding X (2020) Meta-analysis of paclitaxel-based chemotherapy combined with traditional Chinese Medicines for gastric cancer treatment. Front Pharmacol 11:132","journal-title":"Front Pharmacol"},{"key":"4182_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109060","volume":"117","author":"LL Miao","year":"2019","unstructured":"Miao LL, Zhou QM, Peng C, Liu ZH, Xiong L (2019) Leonurus japonicus (Chinese motherwort), an excellent traditional medicine for obstetrical and gynecological diseases: a comprehensive overview. Biomed Pharmacother 117:109060","journal-title":"Biomed Pharmacother"},{"key":"4182_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.sjbs.2017.01.039","volume":"24","author":"M Miao","year":"2017","unstructured":"Miao M, Wang T, Lou X, MingBai XP, Liu B, Chang B (2017) The influence of stachydrine hydrochloride on the reperfusion model of mice with repetitive cerebral ischemia. Saudi J Biol Sci 24:658\u2013663","journal-title":"Saudi J Biol Sci"},{"key":"4182_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/bjc.2017.391","volume":"118","author":"AR Noble","year":"2018","unstructured":"Noble AR, Maitland NJ, Berney DM, Rumsby MG (2018) Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation. Br J Cancer 118:189\u2013199","journal-title":"Br J Cancer"},{"key":"4182_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1054\/bjoc.2000.1658","volume":"84","author":"A Paradiso","year":"2001","unstructured":"Paradiso A, Simone G, Lena MD, Leone B, Vallejo C, Lacava J, Dellapasqua S, Daidone MG, Costa A (2001) Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer. Br J Cancer 84:651\u2013658","journal-title":"Br J Cancer"},{"key":"4182_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.811578","volume":"12","author":"A Ramirez-de-Arellano","year":"2021","unstructured":"Ramirez-de-Arellano A, Pereira-Suarez AL, Rico-Fuentes C, Lopez-Pulido EI, Villegas-Pineda JC, Sierra-Diaz E (2021) Distribution and effects of estrogen receptors in prostate cancer: associated molecular mechanisms. Front Endocrinol (Lausanne) 12:811578","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4182_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of Prostate Cancer. World J Oncol 10:63\u201389","journal-title":"World J Oncol"},{"key":"4182_CR27","doi-asserted-by":"crossref","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S (2022) Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules 27","DOI":"10.3390\/molecules27175730"},{"key":"4182_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1159\/000217264","volume":"76","author":"A Sella","year":"2009","unstructured":"Sella A, Yarom N, Zisman A, Kovel S (2009) Paclitaxel, estramustine and carboplatin combination chemotherapy after initial docetaxel-based chemotherapy in castration-resistant prostate cancer. Oncology 76:442\u2013446","journal-title":"Oncology"},{"key":"4182_CR29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","volume":"6","author":"U Swami","year":"2020","unstructured":"Swami U, McFarland TR, Nussenzveig R, Agarwal N (2020) Advanced prostate cancer: treatment advances and future directions. Trends Cancer 6:702\u2013715","journal-title":"Trends Cancer"},{"key":"4182_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/pros.20581","volume":"67","author":"M Takeda","year":"2007","unstructured":"Takeda M, Mizokami A, Mamiya K, Li YQ, Zhang J, Keller ET, Namiki M (2007) The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines. Prostate 67:955\u2013967","journal-title":"Prostate"},{"key":"4182_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","volume":"70","author":"MY Teo","year":"2019","unstructured":"Teo MY, Rathkopf DE, Kantoff P (2019) Treatment of advanced prostate cancer. Annu Rev Med 70:479\u2013499","journal-title":"Annu Rev Med"},{"key":"4182_CR32","doi-asserted-by":"crossref","unstructured":"Tian Y, Lei Y, Wang Y, Lai J, Wang J, Xia F (2023) Mechanism of multidrug resistance to chemotherapy mediated by P\u2011glycoprotein (Review). Int J Oncol 63","DOI":"10.3892\/ijo.2023.5567"},{"key":"4182_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrd4068","volume":"12","author":"D Trewartha","year":"2013","unstructured":"Trewartha D, Carter K (2013) Advances in prostate cancer treatment. Nat Rev Drug Discov 12:823\u2013824","journal-title":"Nat Rev Drug Discov"},{"key":"4182_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.urology.2004.10.033","volume":"65","author":"S Urakami","year":"2005","unstructured":"Urakami S, Yoshino T, Kikuno N, Imai S, Honda S, Yoneda T, Kishi H, Shigeno K, Shiina H, Igawa M (2005) Docetaxel-based chemotherapy as second-line treatment for paclitaxel-based chemotherapy-resistant hormone-refractory prostate cancer: a pilot study. Urology 65:543\u2013548","journal-title":"Urology"},{"key":"4182_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41391-022-00583-w","volume":"26","author":"Y Wang","year":"2023","unstructured":"Wang Y, Ma Y, Jiang K (2023) The role of ferroptosis in prostate cancer: a novel therapeutic strategy. Prostate Cancer Prostatic Dis 26:25\u201329","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4182_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.11648\/j.ajcem.20140206.18","volume":"2","author":"CR Yeh","year":"2014","unstructured":"Yeh CR, Da J, Song W, Fazili A, Yeh S (2014) Estrogen receptors in prostate development and cancer. Am J Clin Exp Urol 2:161\u2013168","journal-title":"Am J Clin Exp Urol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04182-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04182-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04182-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:14:04Z","timestamp":1759983244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04182-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4182"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04182-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study did not require an ethical board approval because it did not contain human or animal trials.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}